Drug
Auranofin clinical trials
Also written Ridaura.
- studies test it
- 12
- open now
- 1
- in phase 3
- 0
- first study started
- 2011
Keep track of what changes. Save the Auranofin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 4
- Phase 2
- 8
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 12
Mayo Clinic (5) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Federal University of São Paulo (2) · University of Kansas Medical Center (1) · The Aurum Institute NPC (1) · Vaccine and Gene Therapy Institute, Florida (1)
Often tested with
Tested in the same studies.
Sirolimus (3) · Maraviroc (2) · Dolutegravir (2) · Dendritic Cell Vaccine (2) · Niacinamide (2) · Everolimus (1) · Cholecalciferol (1) · CC-11050 (1)
Studies
Open first, then newest update. How each study uses Auranofin is read from its arms, and is right about nine times in ten.
Testing it · 12
- Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without AntiretroviralsRecruitingPhase 2Federal University of São PauloNCT06805656Written as Auranofin
- Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung CancerCompletedPhase 1/2Mayo ClinicNCT01737502Written as Auranofin
- Auranofin and Sirolimus in Treating Participants With Ovarian CancerTerminatedPhase 2Mayo ClinicNCT03456700Written as Auranofin
- Auranofin for Giardia ProtozoaCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT02736968Written as Auranofin
- Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing CureCompletedNot applicableFederal University of São PauloNCT02961829Written as Auranofin
- Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedEarly Phase 1Mayo ClinicNCT01747798Written as auranofin
- Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain SyndromeCompletedPhase 2Mayo ClinicNCT02063698Written as auranofin
- TB Host Directed TherapyStatus unknownPhase 2The Aurum Institute NPCNCT02968927Written as Auranofin 6 MG
- Auranofin PK Following Oral Dose AdministrationCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02089048Written as Auranofin
- Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung CancerWithdrawnPhase 1Mayo ClinicNCT02126527Written as auranofin
- Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)CompletedPhase 2University of Kansas Medical CenterNCT01419691Written as auranofin
- Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV InfectionWithdrawnPhase 1/2Vaccine and Gene Therapy Institute, FloridaNCT02176135Written as Auranofin
Given in every arm · 1 — Auranofin is usual care beside what is tested
Codes
What other systems call Auranofin · ClinicalTrials.gg INT007034
- MeSH (NLM) D001310AuranofinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 3H04W2810VAURANOFINConfirmed FDA, NLM, Wikidata
- RxNorm 1227Confirmed FDA, Wikidata
- Wikidata Q421230auranofinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65242AuranofinOne source FDA
- DrugBank DB00995One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001310 | Auranofin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 3H04W2810V | AURANOFIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1227 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421230 | auranofin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65242 | Auranofin | One source FDA |
| DrugBank | DB00995 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.